Clinical Trial Update: Glucolipotoxicity and Type 2 Diabetes [NA]

View source ↗

Summary

This entry notes that the Rigshospitalet-sponsored clinical trial on glucolipotoxicity and Type 2 Diabetes Mellitus has completed. No specific drug data are pro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Type 2 Diabetes Mellitus | NA | Status: COMPLETED